
AC Immune
Clinical stage Swiss-based biopharmaceutical company focused on neurodegenerative diseases.
Enterprise value
$54m
Share price
$2.05 ACIU
Company register number
CH-270.4.013.417-2
Authorizing premium user...
Clinical stage Swiss-based biopharmaceutical company focused on neurodegenerative diseases.